Cefotaxime
Cefotaxime is a third-generation Cephalosporin antibiotic. It was first patented in 1976 and came into medical use in 1980. Cefotaxime is used to treat a variety of bacterial infections, including those caused by Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae, Neisseria gonorrhoeae, and others.
Chemistry[edit | edit source]
Cefotaxime is a semi-synthetic, beta-lactam antibiotic, which is resistant to most beta-lactamases. It is derived from Cephalosporin C, a naturally occurring antibiotic produced by the fungus Acremonium. Cefotaxime works by inhibiting the synthesis of the bacterial cell wall, leading to cell death.
Pharmacology[edit | edit source]
Cefotaxime is administered either by intravenous or intramuscular injection. It is metabolized in the body and excreted in the urine. The half-life of cefotaxime is approximately one hour in adults.
Clinical Use[edit | edit source]
Cefotaxime is used to treat a wide range of infections, including pneumonia, meningitis, gonorrhea, and infections of the skin, urinary tract, and abdomen. It is also used for surgical prophylaxis in patients undergoing abdominal or pelvic surgery.
Side Effects[edit | edit source]
Common side effects of cefotaxime include rash, diarrhea, and changes in white blood cell count. Serious side effects may include Clostridium difficile infection, allergic reactions, and seizures.
Resistance[edit | edit source]
Resistance to cefotaxime and other cephalosporins can occur through several mechanisms, including the production of beta-lactamase enzymes, alteration of penicillin-binding proteins, and efflux pumps.
See Also[edit | edit source]
- Cefaclor (2nd)
- Cefadroxil (1st)
- Cefdinir (3rd)
- Cefditoren (3rd)
- Cefixime (3rd)
- Cefpodoxime (3rd)
- Cefprozil (2nd)
- Ceftibuten (1st)
- Cephalexin (1st)
- Cefuroxime (2nd)
- Cephradine (1st)
- Loracarbef (2nd)
- Cefazolin (1st)
- Cefepime (4th)
- Cefoperazone (3rd)
- Cefotaxime (3rd)
- Cefoxitin (2nd)
- Ceftaroline (5th)
- Ceftazidime (3rd)
- Ceftibuten (3rd)
- Ceftizoxime (3rd)
- Ceftolozane/Tazobactam (5th)
- Cefuroxime (2nd)
- Cephradine (1st)
- Ceftriaxone (3rd)
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
